Development of a psychotherapy intervention module to help the caregivers of persons with schizophrenia in dealing with caregivers roles and responsibilities

Enabling caregivers of patients with schizophrenia in dealing with psychosocial issues related to caregiving through a comprehensive CBT-informed, strength-based, culturally suited intervention: An open-label RCT study - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063961

Enrollment

Registered

2024-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CBT-informed, strength-based, culturally suited intervention for caregivers of patients with schizophrenia: With the help of experts in the field of schizophrenia and Cognitive Behaviou

Eligibility

Inclusion criteria

Inclusion criteria: (1) A parent (mother or father) playing major carer role in terms of providing support for various needs (such as financial needs, supervision of medication, medical consultation, emotional support and encouragement etc.). (2)Face-to-face contact with the patient for, at least 10 hours a week. (3)The illness duration of the patient whose care the parent is involved in, should be at least one year. (4)Involved in caregiving for last, at least, 6 months (5)At least, 10 years of education (6)Comfortable with the use of technology such as video conferencing facility

Exclusion criteria

Exclusion criteria: (1)A caregiver having an intellectual developmental disability (clinically determined) that impairs their understanding of therapy content (2)Having any major psychiatric illness (excluding subclinical depression as indicated by BDI score of 12 or less) precluding participation in therapy (e.g. severely depressed, highly aroused)

Design outcomes

Primary

Measure	Time frame
(1) Reduction in Psychological distress (2) reduction in Expressed emotion (3) reduction in Hopelessness (4) enhanced Coping to the stressors (5) reduction in Perceived caregiver burden Timepoint: 1st time point: Baseline (at the time of random allocation of the participants to the treatment or waitlist control groups. 2nd time-point: After 5 weeks of Baseline intervention 3rd time-point: After 8 weeks of 2nd assessment	—

Measure

Time frame

(1) Reduction in Psychological distress (2) reduction in Expressed emotion (3) reduction in Hopelessness (4) enhanced Coping to the stressors (5) reduction in Perceived caregiver burden Timepoint: 1st time point: Baseline (at the time of random allocation of the participants to the treatment or waitlist control groups. 2nd time-point: After 5 weeks of Baseline intervention 3rd time-point: After 8 weeks of 2nd assessment

—

Secondary

Measure	Time frame
The caregivers’ satisfaction with the developed intervention, their perceived impact of the therapy module, identification of the motivational facilitators & barriers towards undergoing the therapy module, suggestions on improvement of the therapy module etc.Timepoint: After 5 weeks of baseline assessment (when the intervention will be over)	—

Countries

India

Contacts

Public ContactDevvarta Kumar

National Institute of Mental Health and Neurosciences

devvarta.k@nimhans.ac.in08026995188

Outcome results